Previous Article | Next Article ![]()
J. Virol., Mar 1997, 2292-2302, Vol 71, No. 3
LL An and JL Whitton
The development of safe and effective vaccines remains a major goal in the
prevention, and perhaps treatment, of infectious diseases. Ideally, a
single vaccine would confer protection against several pathogens and would
induce both cellular and humoral arms of the immune response. We originally
demonstrated that two virus-specific cytotoxic T-lymphocyte (CTL) epitopes,
from the same virus but presented by different major histocompatibility
complex alleles, when linked in tandem as minigenes in a recombinant
vaccinia virus, could confer complete protection against subsequent viral
challenge. In the study, we extended this approach, which we termed string
of beads, expanding the immunogenic scope in two ways: first, by
introduction of T helper (Th) and B-cell (antibody) epitopes alongside CTL
epitopes and second, by including immunogenic sequences from a variety of
infectious agents, five viruses and one bacterium. The vaccine (VV-sv)
comprises CTL epitopes from Sendai virus, respiratory syncytial virus, and
lymphocytic choriomeningitis virus (LCMV); Th epitopes from vesicular
stomatitis virus and Mycobacterium tuberculosis; and an antibody epitope
from mengovirus. The construct contains a single start codon, and the
epitopes are linked directly, without intervening spacer amino acids. There
was some concern that the combination of several normally immunodominant
epitopes might result in a new hierarchy of dominance, in which certain
epitopes predominated and others exhibited reduced immunogenicity. However
we show that when analyzed in tissue culture and in vivo, all six epitopes
are expressed. CTL and Th cells are induced in vivo, along with
neutralizing antibody. The induced immunity is biologically relevant: after
VV-sv immunization, the antimengovirus antibody confers protection against
mengovirus challenge. Similarly, CTL induced by the LCMV epitope protected
mice against challenge with this agent. Thus, a polyvalent, minigene-based
vaccine can simultaneously induce several classes of immune response and
thereby can confer protection against diverse pathogens.
Copyright © 1997, American Society for Microbiology
A multivalent minigene vaccine, containing B-cell, cytotoxic T- lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen
Department of Neuropharmacology, CVN-9, The Scripps Research Institute, La Jolla, California 92037, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»